AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7536831
Drug: Atole (163
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atole (163 kcal/682 kJ, 11.5 g protein per cup)
Trial: 7536831
Drug: Fresco (59
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresco (59 kcal/247 kJ, 0 g protein per cup)
Trial: 2109473
Drug: Flumazenil 1
RxNorm normalized name: flumazenil 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil 1 mg (Group B)
Trial: 6993588
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin G treatment
Trial: 6175803
Drug: Alinidine 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alinidine 80 mg
Trial: 6849740
Drug: Hydralazine 50
RxNorm normalized name: hydralazine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine 50 mg
Trial: 6849740
Drug: Alinidine 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alinidine 80 mg combined with Hydralazine 50 mg
Trial: 6849740
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg combined with Hydralazine 50 mg
Trial: 22536858
Drug: Standard topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard topical lidocaine‐4% cream and 99mTc‐sulfur colloid injection
Trial: 22536858
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream and 99mTc‐sulfur colloid injection containing NaHCO3
Trial: 10503752
Drug: Carbohydrate ingestion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate ingestion (4 kcal x kg(-1) oral carbohydrate beverage)
Trial: 1922863
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg P.O. the evening before surgery
Trial: 1922863
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg P.O. the evening before surgery
Trial: 1922863
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg I.M. 90 min before induction of anaesthesia
Trial: 1922863
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug with H2‐antagonist effect
Trial: 10892417
Drug: Beta-agonists
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-agonists
Trial: 29771804
Drug: Preemptive analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive analgesia (oral acetaminophen and gabapentin followed by intravenous ketamine and dexamethasone)
Trial: 29771804
Drug: Control (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (oral placebos)
Trial: 26406550
Drug: Symptomatic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic and supportive treatments (group B)
Trial: 22295819
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy in dog days (group A)
Trial: 22295819
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy in non-dog days (group B)
Trial: 20972736
Drug: Gliclazide plus
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide plus metformin (GLIMET)
Trial: 20972736
Drug: Metformin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin alone (MET)
Trial: 17110073
Drug: Soy-based formulation
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy-based formulation containing pure soy standardized extract of isoflavones
Trial: 17110073
Drug: Soy-based formulation
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy-based formulation containing soy flour in addition to the standardized extract of isoflavones
Trial: 17110073
Drug: Equol producers
RxNorm normalized name: equol, (+-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equol producers with equol excretion added to daidzein excretion
Trial: 15677794
Drug: Repaglinide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (1 mg twice a day)
Trial: 15677794
Drug: Glibenclamide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (5 mg twice a day)
Trial: 16009690
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg twice daily
Trial: 2270941
Drug: Human isophane
RxNorm normalized name: Human isophane insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human isophane insulin
Trial: 31814522
Drug: Oral stimulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral stimulation protocol (10 minutes)
Trial: 27761668
Drug: Extraoral infrared
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraoral infrared light therapy for 20 min daily with at least 80% compliance (n=20)
Trial: 26362959
Drug: Paracetamol-codeine phosphate
RxNorm normalized name: codeine and paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol-codeine phosphate (300 mg + 30 mg)
Trial: 26362959
Drug: Naproxen sodium-codeine
RxNorm normalized name: Naproxen Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen sodium-codeine phosphate (550 mg + 30 mg)
Trial: 22672359
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment group (n=14)
Trial: 22672359
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment group (n=13)
Trial: 21720655
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream 1% applied twice daily
Trial: 21720655
Drug: Topical medical
RxNorm normalized name: Procto-Med Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical medical device cream applied three times daily
Trial: 19179127
Drug: Bismuth 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth 240 mg bis in die for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Trial: 19179127
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg once a day for 14 days combined with amoxicillin 1g plus metronidazole 250 mg tris in die for the first week
Trial: 3891436
Drug: Topical antihistaminics
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antihistaminics
Trial: 19151050
Drug: Topical levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical levobupivacaine 0.75%
Trial: 19151050
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine 2%
Trial: 15054437
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (VA) supplementation (210 micromol) and deworming (400 mg albendazole) in Group 1 (VA administered > or = 4 months before baseline)
Trial: 15054437
Drug: VA delivered
RxNorm normalized name: VP/VA COPOLYMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VA delivered through the public health system in Group 2 (VA administered < or = 1 month before baseline)
Trial: 9071556
Drug: 2.5% hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% hydrocortisone ointment
Trial: 7527736
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (CAP or modified M-VAC)
Trial: 7527736
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (modified M-VAC or MEC)
Trial: 4391702
Drug: Alprenolol 100
RxNorm normalized name: alprenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprenolol 100 mg four times daily
Trial: 4391702
Drug: Pentanitrol 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentanitrol 30 mg four times daily
Trial: 23388588
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg 30 minutes before bedtime for 6 weeks
Trial: 23388588
Drug: Clonazepam 2
RxNorm normalized name: clonazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 2 mg at night (with gradual titration over 4 weeks from 0.5 mg)
Trial: 19045977
Drug: 8-week Internet-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week Internet-based cognitive behavior therapy program with minimal therapist contact via e-mail and weekly telephone calls of less than 15 min
Trial: 15949095
Drug: 0.05% solution
RxNorm normalized name: Equate Nasal Spray 0.05% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% solution of betamethasone dipropionate (BD)
Trial: 14627440
Drug: Isoflavones tablets
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavones tablets
Trial: 9380298
Drug: Estrogens (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogens (0.15 or 0.3 or 0.625 mg)
Trial: 8436494
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium (100mg, two capsules a day for 15 days)
Trial: 27568900
Drug: Zolpidem nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem nasal spray 1.75 mg
Trial: 27568900
Drug: Zolpidem nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem nasal spray 3.5 mg
Trial: 27568900
Drug: Zolpidem nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem nasal spray 5.0 mg
Trial: 27568900
Drug: Zolpidem nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem nasal spray (1.75 mg, 3.5 mg, 5.0 mg)
Trial: 27568900
Drug: Zolpidem nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem nasal spray
Trial: 21152784
Drug: cream with
RxNorm normalized name: CREAM WITH APPLICATOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cream with Belides, Emblica and Licorice 7%, applied twice a day
Trial: 21152784
Drug: cream with
RxNorm normalized name: CREAM WITH APPLICATOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cream with Hydroquinone 2%, used at night
Trial: 12151444
Drug: Physician-Administered Sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician-Administered Sedation (PAS)
Trial: 8622041
Drug: Protocol 77-04
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol 77-04 (15 cycles of CTX, ADR, PRED, VCR, high-dose MTX, and IT therapy)
Trial: 3780987
Drug: Breast conserving
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast conserving treatment (tumorectomy followed by radiotherapy)
Trial: 3780987
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (mastectomy and breast conserving treatment)
Trial: 25088437
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (target HbA1c less than 42 mmol/mol or less than 6·0%)
Trial: 25088437
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (target HbA1c 53‐63 mmol/mol or 7·0‐7·9%)
Trial: 15980686
Drug: Indinavir (IDV)/ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir (IDV)/ritonavir (RTV)‐containing highly active antiretroviral (ARV) therapy regimens
Trial: 12705178
Drug: Triclabendazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triclabendazole (10 mg/kg body weight, two consecutive oral doses)
Trial: 12705178
Drug: Triclabendazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triclabendazole (10 mg/kg body weight) + Vitamin C (1000 mg/day) + Vitamin E (600 mg/day) for two months
Trial: 6784224
Drug: Bacampicillin 400
RxNorm normalized name: bacampicillin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 400 mg twice a day
Trial: 6784224
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 250 mg four times a day
Trial: 6784224
Drug: Amoxicillin 250
RxNorm normalized name: amoxicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 250 mg every 8 hr
Trial: 30698316
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus CABG (MED/CABG)
Trial: 30698316
Drug: Interaction between
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interaction between CCI score and treatment effect
Trial: 26346470
Drug: Vitamin D3-fortified
RxNorm normalized name: vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3-fortified doogh (FD), containing 12.5 μg/250 ml, taken twice a day for 12 weeks
Trial: 26346470
Drug: Plain doogh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain doogh (PD), containing no vitamin D, taken twice a day for 12 weeks
Trial: 17965789
Drug: Bowel preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bowel preparation (lactulose 2 days before surgery and rectal enema on the day of surgery)
Trial: 17965789
Drug: No bowel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No bowel preparation (Control Group II)
Trial: 15379121
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy consisting of 5-day courses of cytostatic drugs alternating or not alternating with 5-day courses of ATRA
Trial: 26287319
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (PCF) with surgery
Trial: 26287319
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy alone
Trial: 21076271
Drug: HBV-active antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBV-active antiretroviral therapy (ART) for 48 weeks
Trial: 12712958
Drug: AIDSVAX vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDSVAX vaccine
Trial: 10736331
Drug: Dietary diacylglycerol
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary diacylglycerol (DG) - 10 g/d
Trial: 10736331
Drug: Triacylglycerol (TG)
RxNorm normalized name: TG-1042
DrugBank: TG-1042 (DB18435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triacylglycerol (TG) - 10 g/d (control)
Trial: 8737101
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g MgSO4 bolus followed by 4 g MgSO4 for 24 h
Trial: 8737101
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g MgSO4 bolus followed by 14 g MgSO4 for 24 h
Trial: 1560192
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement treatment
Trial: 2862464
Drug: Dry powdered
RxNorm normalized name: Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry powdered surfactant (25 mg) insufflated through the endotracheal tube
Trial: 17899018
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oxycodone
Trial: 23163142
Drug: Qudu Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qudu Granule (QG), orally taken, 5 g each time, 3 times a day for over 12 months.
Trial: 23163142
Drug: Niaoduqing granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niaoduqing granule (NG), orally taken, 5 g each time, 3 times a day for over 12 months.
Trial: 20380284
Drug: Chemo-radiotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-radiotherapy with Temodal (75 mg/m2)
Trial: 20380284
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy only (60 Gy, fractionated into 5 x 2 Gy weekly)
Trial: 15653517
Drug: Lactobacillus acidophilus
RxNorm normalized name: Lactobacillus acidophilus
DrugBank: Lactobacillus acidophilus (DB15823)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus acidophilus strain L-92 (100 mL of heat-treated fermented milk)
Trial: 10235522
Drug: Blood cardioplegia
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood cardioplegia containing 2 mM adenosine and adenosine infusion (200 microg/kg/min) before and after aortic crossclamp removal
Trial: 8909453
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human ciliary neurotrophic factor (rhCNTF) at doses ranging from 2 to 100 micrograms/kg
Trial: 8909453
Drug: daily subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: daily subcutaneous rhCNTF at doses < or = 5 micrograms/kg/day
Trial: 8909453
Drug: daily subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: daily subcutaneous rhCNTF at higher doses
Trial: 1810522
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% meclofenamic acid gel
Trial: 1810522
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium meclofenamate capsules
Trial: 1810522
Drug: Sodium naproxen
RxNorm normalized name: Naproxen Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium naproxen capsules
Trial: 6406441
Drug: Bupropion 150
RxNorm normalized name: BUPROPION 150MG (SMK-C) 12HR SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion 150 mg/day
Trial: 6406435
Drug: Bupropion 450
RxNorm normalized name: buPROPion 450 mg/24 hours oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion 450 mg/day
Trial: 22869581
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate monotherapy at 2 mg/kg/day for 7 days
Trial: 22869581
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate monotherapy at 4 mg/kg/day for 7 days
Trial: 22869581
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate monotherapy at 6 mg/kg/day for 7 days
Trial: 22869581
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate monotherapy
Trial: 17055329
Drug: APO (apomorphine)
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: APO (apomorphine) at typically effective dose (TED)
Trial: 14530901
Drug: Memantine (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (0 mg)
Trial: 14530901
Drug: Memantine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (15 mg)
Trial: 9710711
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 35 mg ethinylestradiol and 2 mg cyproterone acetate
Trial: 9710711
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 30 mg ethinylestradiol and 150 mg desogestrel
Trial: 7663660
Drug: Aerosolised rhDNase
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolised rhDNase 2.5 mg twice daily
Trial: 7663660
Drug: Aerosolised rhDNase
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolised rhDNase 2.5 mg twice daily (open-label phase)
Trial: 27869649
Drug: Calcipotriol (0.005%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol (0.005% ointment) combined with 5-fluorouracil (5% cream)
Trial: 27869649
Drug: Vaseline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaseline plus 5-fluorouracil (5% cream)
Trial: 21593096
Drug: Full length
RxNorm normalized name: antihemophilic factor (FVIII) rec, full length
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full length 5 degree lateral wedged insoles worn daily for 12 months
Trial: 21593096
Drug: Flat control
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flat control insoles worn daily for 12 months
Trial: 9215091
Drug: Valaciclovir (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir (500 mg once daily)
Trial: 8314294
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g cefuroxime i.v. as a single bolus 20 minutes before surgical incision